Overcoming challenges in a Patient-based PK study (Paliperidone) held during the COVID-19 pandemic
- Post author:Dipesh Chodvadia
- Post published:November 30, 2023
- Post category:Case-Study
You Might Also Like
Delivering a Global Multicenter Denosumab Clinical Trial with Integrated Clinical and Bioanalytical Expertise
From Study Execution to EMA Success A Global Phase III Program for Ranibizumab – Ophthalmic Biosimilar